Table 1.
Current viral and bacterial vaccines and type of vaccine
| Vaccine | Type |
|---|---|
| Viral | |
| Smallpox (vaccinia) | 1 |
| Yellow fever | 1 |
| Polio (oral polio vaccine) | 1 |
| Polio (inactivated polio vaccine) | 2 |
| Measles | 1 |
| Mumps | 1 |
| Rubella | 1 |
| Varicella | 1 |
| Adeno | 1 |
| Influenza | 1a, 2, 3 |
| Japanese encephalitis | 2 |
| Rabies | 2 |
| Hepatitis A | 2 |
| Hepatitis B | 3 |
| Bacterial | |
| Bacille Calmette−Guerin (tuberculosis) | 1 |
| Salmonella typhi | 1, 5, 6 † |
| Bordetella pertussis | 2, 3 |
| Vibrio cholerae | 1 |
| Bacillus anthracis | 2 |
| Coxiella burnetii (Q fever) | 2 |
| Borrelia burgdorferi (lyme disease) | 3 |
| Clostridium tetani | 4 |
| Corynebacterium diphtheriae | 4 |
| Streptococcus pneumoniae | 5, 6 † |
| Haemophilus influenzae, type b (Hib) | 6 |
| Neisseria meningiditis group A.C,W135,Y | 5 |
| Neisseria meningiditis group B | 3 † |
| Neisseria meningiditis group C | 6 |
| Combination | |
| Diphtheria tetanus whole pertussis | |
| Diphtheria tetanus acellular pertussis | |
| Measles, mumps, rubella | |
| Hib‐hep B, DTaP‐hep B | |
1, live attenuated; 1a, live, reassortant (used successfully in Russia); 2, whole particle, inactivated; 3, subunit; 4, toxoid; 5, polysaccharide; 6, carbohydrate/protein conjugate. †Passed phase 3 clinical trials.